Akero Therapeutics Future Growth
Future criteria checks 0/6
Akero Therapeutics is forecast to grow earnings and revenue by 5.1% and 69.6% per annum respectively. EPS is expected to grow by 9.1% per annum. Return on equity is forecast to be -115.5% in 3 years.
Key information
5.1%
Earnings growth rate
9.1%
EPS growth rate
Biotechs earnings growth | 23.2% |
Revenue growth rate | 69.6% |
Future return on equity | -115.5% |
Analyst coverage | Good |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Akero Therapeutics' EFX Data Warrants Caution
Apr 03Akero: Phase 2b NASH Data Bodes Well For Phase 3 SYNCHRONY Program
Mar 04Akero Therapeutics announces closing of upsized public offering
Sep 19Akero adds over 100% rallying peers after NASH success
Sep 13We're Not Very Worried About Akero Therapeutics' (NASDAQ:AKRO) Cash Burn Rate
May 04We Think Akero Therapeutics (NASDAQ:AKRO) Can Afford To Drive Business Growth
Jan 15Akero Therapeutics (NASDAQ:AKRO) Is In A Good Position To Deliver On Growth Plans
Oct 01Akero: Ticking All The Right Boxes In NASH
Sep 23Akero Therapeutics (NASDAQ:AKRO) Is In A Good Position To Deliver On Growth Plans
Jun 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 15 | -284 | -214 | -252 | 5 |
12/31/2025 | N/A | -274 | -209 | -269 | 5 |
12/31/2024 | N/A | -233 | -153 | -192 | 6 |
12/31/2023 | N/A | -152 | -145 | -145 | N/A |
9/30/2023 | N/A | -120 | -122 | -122 | N/A |
6/30/2023 | N/A | -116 | -97 | -97 | N/A |
3/31/2023 | N/A | -112 | -94 | -94 | N/A |
12/31/2022 | N/A | -112 | -93 | -93 | N/A |
9/30/2022 | N/A | -121 | -94 | -94 | N/A |
6/30/2022 | N/A | -110 | -84 | -84 | N/A |
3/31/2022 | N/A | -112 | -84 | -84 | N/A |
12/31/2021 | N/A | -101 | -80 | -80 | N/A |
9/30/2021 | N/A | -98 | -76 | -76 | N/A |
6/30/2021 | N/A | -95 | -75 | -75 | N/A |
3/31/2021 | N/A | -82 | -78 | -78 | N/A |
12/31/2020 | N/A | -79 | -71 | -71 | N/A |
9/30/2020 | N/A | -65 | -59 | -59 | N/A |
6/30/2020 | N/A | -59 | -59 | -59 | N/A |
3/31/2020 | N/A | -50 | -41 | -41 | N/A |
12/31/2019 | N/A | -44 | -36 | -36 | N/A |
9/30/2019 | N/A | -90 | -26 | -26 | N/A |
6/30/2019 | N/A | -86 | -15 | -15 | N/A |
3/31/2019 | N/A | -87 | -15 | -10 | N/A |
12/31/2018 | N/A | -82 | -10 | -5 | N/A |
9/30/2018 | N/A | -22 | -9 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKRO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AKRO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AKRO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AKRO is forecast to have no revenue next year.
High Growth Revenue: AKRO is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKRO is forecast to be unprofitable in 3 years.